- B-Raf IN 1
-
- $84.00 / 1mg
-
2026-04-20
- CAS:950736-05-7
- Min. Order:
- Purity: 99.50%
- Supply Ability: 10g
|
| | BenzaMide, N-[3-[3-[4-[(diMethylaMino)Methyl]phenyl]pyrazolo[1,5-a]pyriMidin-7-yl]phenyl]-3-(trifluoroMethyl)- Basic information |
| | BenzaMide, N-[3-[3-[4-[(diMethylaMino)Methyl]phenyl]pyrazolo[1,5-a]pyriMidin-7-yl]phenyl]-3-(trifluoroMethyl)- Chemical Properties |
| density | 1.28±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 14 mg/ml; DMSO: 33 mg/ml; Ethanol: 1 mg/ml | | form | Powder | | pka | 12.75±0.70(Predicted) | | color | Light yellow to yellow |
| | BenzaMide, N-[3-[3-[4-[(diMethylaMino)Methyl]phenyl]pyrazolo[1,5-a]pyriMidin-7-yl]phenyl]-3-(trifluoroMethyl)- Usage And Synthesis |
| Description | B-RAF IN 1 is an inhibitor of B-RAF (IC50 = 24 nM) that also inhibits C-RAF (IC50 = 25 nM). It is selective over 13 other kinases, including PKCα, IKKβ, and PI3Kα, at concentrations greater than 2 μM, but does inhibit p38α and CAMKII (IC50s = 216 and 822 nM, respectively). B-RAF IN 1 binds to B-RAF in the inactive conformation based on co-crystallization with the wild-type enzyme. It inhibits proliferation of WM 266-4 and HT29 cells with IC50 values of 920 and 780 nM, respectively. | | Uses | N-[3-[3-[4-[(Dimethylamino)methyl]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]-3-(trifluoromethyl)benzamide is a potent and selective B-Raf inhibitor. | | IC 50 | B-Raf: 24 nM (IC50) | | References | [1] DAN M. BERGER . Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors[J]. Bioorganic & Medicinal Chemistry Letters, 2009, 19 23: Pages 6519-6523. DOI: 10.1016/j.bmcl.2009.10.049 |
| | BenzaMide, N-[3-[3-[4-[(diMethylaMino)Methyl]phenyl]pyrazolo[1,5-a]pyriMidin-7-yl]phenyl]-3-(trifluoroMethyl)- Preparation Products And Raw materials |
|